Mireia Moreno

1.3k total citations
52 papers, 631 citations indexed

About

Mireia Moreno is a scholar working on Rheumatology, Immunology and Hematology. According to data from OpenAlex, Mireia Moreno has authored 52 papers receiving a total of 631 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Rheumatology, 24 papers in Immunology and 14 papers in Hematology. Recurrent topics in Mireia Moreno's work include Spondyloarthritis Studies and Treatments (30 papers), Psoriasis: Treatment and Pathogenesis (21 papers) and Rheumatoid Arthritis Research and Therapies (18 papers). Mireia Moreno is often cited by papers focused on Spondyloarthritis Studies and Treatments (30 papers), Psoriasis: Treatment and Pathogenesis (21 papers) and Rheumatoid Arthritis Research and Therapies (18 papers). Mireia Moreno collaborates with scholars based in Spain, France and United States. Mireia Moreno's co-authors include Jordi Gratacós, M. Larrosa, C. Orellana, Joan Calvet, Jesús Luelmo, Eduardo Collantes‐Estévez, Marta Arévalo, E. Casado, Raquel Almodóvar and Pilar Font and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Journal of Bone and Joint Surgery.

In The Last Decade

Mireia Moreno

47 papers receiving 624 citations

Peers

Mireia Moreno
Mireia Moreno
Citations per year, relative to Mireia Moreno Mireia Moreno (= 1×) peers Anabela Barcelos

Countries citing papers authored by Mireia Moreno

Since Specialization
Citations

This map shows the geographic impact of Mireia Moreno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mireia Moreno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mireia Moreno more than expected).

Fields of papers citing papers by Mireia Moreno

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mireia Moreno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mireia Moreno. The network helps show where Mireia Moreno may publish in the future.

Co-authorship network of co-authors of Mireia Moreno

This figure shows the co-authorship network connecting the top 25 collaborators of Mireia Moreno. A scholar is included among the top collaborators of Mireia Moreno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mireia Moreno. Mireia Moreno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ladehesa-Pineda, Lourdes, Marta Arévalo, Mireia Moreno, et al.. (2025). Seventeen-year reassessment of diagnostic transitions, biologic therapy initiation and mortality in spondyloarthritis: results from the REGISPON-3 study. RMD Open. 11(4). e006031–e006031.
2.
Moreno, Mireia, et al.. (2024). Insights into New-onset Arthritis in Patients with Hidradenitis Suppurativa. Acta Dermato Venereologica. 104. adv40145–adv40145.
3.
Sallés, Meritxell, Julio Ramírez, Xavier Juanola, et al.. (2023). Dual targeted therapy in patients with psoriatic arthritis and spondyloarthritis: a real-world multicenter experience from Spain. Frontiers in Immunology. 14. 1283251–1283251. 14 indexed citations
4.
Valero, Cristina, Meritxell Sallés, José Ramírez, et al.. (2023). POS1112 COMBINED BIOLOGICAL OR TARGETED THERAPY IN SPONDYLOARTHRITIS: EXPERIENCE FROM A MULTICENTER CASE SERIES IN SPAIN. Annals of the Rheumatic Diseases. 82. 880–881.
5.
Arévalo, Marta, Clementina López‐Medina, Mireia Moreno, et al.. (2020). Role of HLA-B27 in the comorbidities observed in Axial Spondyloarthritis: Data from COMOSPA. Joint Bone Spine. 87(5). 445–448. 14 indexed citations
7.
Moreno, Mireia, Jordi Gratacós, Vicenç Torrente-Segarra, et al.. (2019). Withdrawal of infliximab therapy in ankylosing spondylitis in persistent clinical remission, results from the REMINEA study. Arthritis Research & Therapy. 21(1). 88–88. 23 indexed citations
8.
Almodóvar, Raquel, Loreto Carmona, Ana Urruticoechea‐Arana, et al.. (2018). The EJES-3D tool for personalized prescription of exercise in axial spondyloarthritis through multimedia animations: pilot study. Rheumatology International. 38(7). 1277–1284. 3 indexed citations
9.
Arévalo, Marta, Jordi Gratacós, Mireia Moreno, et al.. (2018). Influence of HLA-B27 on the Ankylosing Spondylitis phenotype: results from the REGISPONSER database. Arthritis Research & Therapy. 20(1). 221–221. 60 indexed citations
10.
Almodóvar, Raquel, Juan Carlos Torre Alonso, Enrique Batlle, et al.. (2017). Desarrollo de un cuadro de actuación para la evaluación de pacientes con espondiloartritis axial y artritis psoriásica en la práctica diaria: proyecto ONLY TOOLS. Reumatología Clínica. 14(3). 155–159. 10 indexed citations
11.
Alonso, Juan Carlos Torre, Raquel Almodóvar, Juan D. Cañete, et al.. (2017). Recomendaciones de la Sociedad Española de Reumatología sobre el tratamiento y uso de terapias sistémicas biológicas y no biológicas en artritis psoriásica. Reumatología Clínica. 14(5). 254–268. 31 indexed citations
12.
Gratacós, Jordi, Mireia Moreno, Pilar Font, et al.. (2016). Etoricoxib in ankylosing spondylitis: is there a role for active patients refractory to traditional NSAIDs?. PubMed. 34(1). 94–9. 7 indexed citations
13.
Corominas, Hèctor, Vera Ortiz-Santamaría, I. Castellví, et al.. (2015). Nailfold capillaroscopic findings in primary Sjögren’s syndrome with and without Raynaud’s phenomenon and/or positive anti-SSA/Ro and anti-SSB/La antibodies. Rheumatology International. 36(3). 365–369. 14 indexed citations
14.
Reina, Dèlia, Vicenç Torrente-Segarra, Dacia Cerdá, et al.. (2015). Sjögren's syndrome-associated interstitial lung disease: A multicenter study. Reumatología Clínica. 12(4). 201–205. 47 indexed citations
15.
Torre‐Alonso, Juan Carlos, Jordi Gratacós, E. Daudén, et al.. (2014). Development and Validation of a New Instrument to Measure Health-related Quality of Life in Patients with Psoriatic Arthritis: The VITACORA-19. The Journal of Rheumatology. 41(10). 2008–2017. 14 indexed citations
16.
Luelmo, Jesús, Jordi Gratacós, Mireia Moreno, et al.. (2014). Experiencia de 4 años de funcionamiento de una unidad multidisciplinar de psoriasis y artritis psoriásica. Reumatología Clínica. 10(3). 141–146. 31 indexed citations
17.
Luelmo, Jesús, Jordi Gratacós, Mireia Moreno, et al.. (2013). Experiencia de 4 años de funcionamiento de una unidad multidisciplinar de psoriasis y artritis psoriásica. Actas Dermo-Sifiliográficas. 105(4). 371–377. 18 indexed citations
18.
Larrosa, M., Antonio Gómez, E. Casado, et al.. (2011). Hypovitaminosis D as a risk factor of hip fracture severity. Osteoporosis International. 23(2). 607–614. 39 indexed citations
19.
Gratacós, Jordi & Mireia Moreno. (2010). La terapia anti-TNF en la espondilitis anquilosante (EA). ¿Es posible suspender el tratamiento?. Reumatología Clínica. 6(5). 237–239. 1 indexed citations
20.
Moreno, Mireia, Jordi Gratacós, E. Casado, et al.. (2007). Utilidad del pamidronato en el tratamiento de la artropatía de Charcot. Reumatología Clínica. 3(6). 257–261. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026